Ron Ellis
Director/Board Member bij GeneQuine Biotherapeutics GmbH
Profiel
Ron Ellis is currently a Director at GeneQuine Biotherapeutics GmbH and CarthroniX, Inc. He was formerly a Chief Strategy Officer at Pacira Biosciences, Inc. Dr. Ellis holds an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Actieve functies van Ron Ellis
Bedrijven | Functie | Begin |
---|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Director/Board Member | - |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Director/Board Member | - |
Eerdere bekende functies van Ron Ellis
Bedrijven | Functie | Einde |
---|---|---|
PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Ron Ellis
St. Joseph's University | Masters Business Admin |
Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PACIRA BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Health Technology |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Health Services |